Jushi Holdings (JUSHF) Liabilities and Shareholders Equity (2021 - 2026)

Jushi Holdings (JUSHF) reported Liabilities and Shareholders Equity of $435.1 million for Q1 2026, little changed year-over-year from $433.6 million in Q1 2025, and up 3.03% quarter-over-quarter from $422.3 million in Q4 2025.

Jushi Holdings (JUSHF) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $435.1 million in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $435.1 million, changed 0.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 billion (down 2.82% YoY), and the FY2025 annual result was $422.3 million, down 4.08% from the prior year.
  • Liabilities and Shareholders Equity advanced to $435.1 million in Q1 2026 per JUSHF's latest filing, from $422.3 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $710.8 million in Q2 2022 and troughed at $422.3 million in Q4 2025.
  • A 5-year average of $499.4 million and a median of $457.8 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2023 and 2026: Liabilities and Shareholders Equity retreated 29.44% in 2023, then advanced 0.35% in 2026.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $529.3 million in 2022, then decreased by 12.46% to $463.4 million in 2023, then dropped by 4.98% to $440.3 million in 2024, then declined by 4.08% to $422.3 million in 2025, then increased by 3.03% to $435.1 million in 2026.
  • Business Quant data shows JUSHF's Liabilities and Shareholders Equity at $435.1 million in Q1 2026, $422.3 million in Q4 2025, and $431.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Jushi Holdings - - 29.88 Mn 435.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 435.14 Mn
Dec 31, 2025 422.34 Mn
Sep 30, 2025 431.70 Mn
Jun 30, 2025 432.37 Mn
Mar 31, 2025 433.62 Mn
Dec 31, 2024 440.32 Mn
Sep 30, 2024 442.33 Mn
Jun 30, 2024 455.23 Mn
Mar 31, 2024 457.85 Mn
Dec 31, 2023 463.40 Mn
Sep 30, 2023 488.67 Mn
Jun 30, 2023 501.49 Mn
Mar 31, 2023 520.04 Mn
Dec 31, 2022 529.34 Mn
Sep 30, 2022 665.41 Mn
Jun 30, 2022 710.77 Mn
Mar 31, 2022 659.55 Mn
Dec 31, 2021 652.05 Mn